Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy.

Mya BojarskyJulia A BaranStephen HaladaAmber IsazaHongming ZhuangLisa StatesFrederick D GrantStephanie RobbinsLindsay SiskoJulio C Ricarte-FilhoKen KazahayaN Scott AdzickSogol Mostoufi-MoabAndrew J Bauer

Published in: The Journal of clinical endocrinology and metabolism (2023)

Withholding RAIT for pediatric patients with ATA low-risk DTC avoids exposure to radiation and does not have a negative impact on remission rates. Dynamic risk stratification at one-year post-initial treatment is a suitable time point to assess the impact of withholding RAIT for these patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
peritoneal dialysis
radiation induced
rheumatoid arthritis
mesenchymal stem cells
metabolic syndrome
magnetic resonance imaging
weight loss
childhood cancer
replacement therapy
patient reported
smoking cessation